QDM PE Ratio 2010-2024 | QDMI
Current and historical p/e ratio for QDM (QDMI) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. QDM PE ratio as of June 04, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| QDM PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-04 | 2.59 | 0.00 | |
| 2024-12-31 | 1.94 | 0 | 0.00 |
| 2024-09-30 | 3.86 | $0.00 | 0.00 |
| 2024-06-30 | 1.21 | $0.00 | 0.00 |
| 2024-03-31 | 15.99 | $0.01 | 0.00 |
| 2023-12-31 | 11.20 | $0.13 | 85.50 |
| 2023-09-30 | 27.00 | $0.10 | 278.35 |
| 2023-06-30 | 1.00 | $0.06 | 16.39 |
| 2023-03-31 | 1.00 | $0.01 | 83.33 |
| 2022-12-31 | 0.81 | $-0.17 | 0.00 |
| 2022-09-30 | 0.81 | $-0.17 | 0.00 |
| 2022-06-30 | 9.10 | $-0.18 | 0.00 |
| 2022-03-31 | 23.00 | $-0.22 | 0.00 |
| 2021-12-31 | 9.50 | $-0.35 | 0.00 |
| 2021-09-30 | 9.88 | $-0.46 | 0.00 |
| 2021-06-30 | 18.06 | $-0.48 | 0.00 |
| 2021-03-31 | 18.00 | $-0.48 | 0.00 |
| 2020-12-31 | 57.00 | $-0.51 | 0.00 |
| 2020-09-30 | 45.00 | $-0.36 | 0.00 |
| 2020-06-30 | 21.03 | $-0.30 | 0.00 |
| 2020-03-31 | 66.30 | $-0.21 | 0.00 |
| 2019-12-31 | 63.39 | 0 | 0.00 |
| 2019-09-30 | 109.20 | 0 | 0.00 |
| 2019-06-30 | 375.00 | 0 | 0.00 |
| 2019-03-31 | 54.00 | 0 | 0.00 |
| 2018-12-31 | 60.00 | 0 | 0.00 |
| 2018-09-30 | 30.00 | 0 | 0.00 |
| 2018-06-30 | 54.00 | 0 | 0.00 |
| 2018-03-31 | 57.00 | $-3.00 | 0.00 |
| 2015-09-30 | 69.00 | $-3.00 | 0.00 |
| 2015-06-30 | 144.00 | $-3.00 | 0.00 |
| 2015-03-31 | 72.00 | $-3.00 | 0.00 |
| 2014-12-31 | 93.30 | 0 | 0.00 |
| 2014-09-30 | 120.00 | 0 | 0.00 |
| 2014-06-30 | 150.00 | 0 | 0.00 |
| 2014-03-31 | 144.00 | $3.00 | 47.95 |
| 2013-12-31 | 60.00 | 0 | 0.00 |
| 2013-09-30 | 180.00 | 0 | 0.00 |
| 2013-06-30 | 177.00 | 0 | 0.00 |
| 2013-03-31 | 210.00 | $-3.00 | 0.00 |
| 2012-12-31 | 231.00 | $-3.00 | 0.00 |
| 2012-09-30 | 165.00 | $-3.00 | 0.00 |
| 2012-06-30 | 93.00 | $-3.00 | 0.00 |
| 2012-03-31 | 114.00 | $-3.00 | 0.00 |
| 2011-12-31 | 82.50 | $-3.00 | 0.00 |
| 2011-09-30 | 120.00 | $-3.00 | 0.00 |
| 2011-06-30 | 135.00 | 0 | 0.00 |
| 2011-03-31 | 178.20 | 0 | 0.00 |
| 2010-12-31 | 165.00 | $3.00 | 54.95 |
| 2010-09-30 | 113.40 | $3.00 | 37.76 |
| 2010-06-30 | 142.50 | 0 | 0.00 |
| 2010-03-31 | 162.00 | 0 | 0.00 |
| 2009-12-31 | 150.00 | $-3.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.743B | $0.006B |
| QDM International Inc. is a telemedicine company which operates principally in Florida and Georgia. It provides Connect-a-Doc telemedicine kits which include digital otoscope, stethoscope, blood pressure cuff, thermometer and high definition, and dental and dermatology cameras for schools, desire to provide healthcare to their students but are unable to keep a full time school nurse available. QDM International Inc., formerly known as 24/7 Kid Doc Inc., is based in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $137.452B | 25.78 |
| Elevance Health (ELV) | United States | $85.620B | 11.05 |
| CVS Health (CVS) | United States | $80.443B | 10.00 |
| Cencora (COR) | United States | $56.509B | 19.66 |
| Natera (NTRA) | United States | $21.868B | 0.00 |
| DiDi Global (DIDIY) | China | $21.650B | 32.86 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $12.848B | 13.60 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.645B | 0.00 |
| CochLear (CHEOY) | Australia | $11.378B | 0.00 |
| ICON (ICLR) | Ireland | $10.802B | 10.04 |
| Revvity (RVTY) | United States | $10.730B | 18.47 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| Doximity (DOCS) | United States | $10.051B | 46.53 |
| HealthEquity (HQY) | United States | $8.975B | 39.30 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| Medpace Holdings (MEDP) | United States | $8.797B | 23.36 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.802B | 13.33 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.121B | 38.15 |
| Bausch + Lomb (BLCO) | Canada | $4.065B | 23.96 |
| Sotera Health (SHC) | United States | $3.486B | 19.81 |
| Alignment Healthcare (ALHC) | United States | $3.035B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.984B | 38.80 |
| Concentras Parent (CON) | United States | $2.776B | 16.04 |
| Organon (OGN) | United States | $2.454B | 2.61 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.078B | 80.01 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.884B | 41.47 |
| PACS (PACS) | United States | $1.554B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.407B | 28.14 |
| Teladoc Health (TDOC) | United States | $1.239B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.186B | 9.02 |
| Establishment Labs Holdings (ESTA) | $1.061B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.971B | 15.16 |
| Agilon Health (AGL) | United States | $0.940B | 0.00 |
| Nutex Health (NUTX) | United States | $0.825B | 12.46 |
| AMN Healthcare Services Inc (AMN) | United States | $0.783B | 7.33 |
| Embecta (EMBC) | United States | $0.620B | 4.18 |
| LifeMD (LFMD) | United States | $0.575B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| SBC Medicals (SBC) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.491B | 11.07 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.254B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| DocGo (DCGO) | United States | $0.151B | 24.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.094B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| ModivCare (MODV) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |